Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Unlock unique experiences with your credit card points. Learn how to make the most of your rewards effectively.
17,266 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
TD Bank has been on investors' radars, but sustained upside hinges on three core drivers. Explore how regulatory shif...
Home Depot’s stock surge followed a better-than-expected quarterly showing, with comps rising and margins improving. ...
The bitcoin price rally riding on record U.S. margin debt has traders on edge. Analysts warn a swift unwind could arr...
Cavco stock rose about 9% over the past year even as a large fund pulled roughly $12 million in Cavco shares. This ar...
Bitcoin reclaims the $70,000 level as macro tensions and a large options stack around the strike drive hedging flows....
Markets staged a broad reversal as crude collapsed and investors priced in a potential de-escalation in a tense geopo...
A high-profile Arkansas event sparked financial ripples as sponsors and donors paused amid controversy. This article ...
As oil approaches the $100 threshold, major energy producers could boost dividends and buybacks. Here's which names c...
As investors await Hyperfine's HYPR 2025 earnings, this guide breaks down what the numbers could show, how to read th...
Prosecutors are reviewing a retrial letter from Sam Bankman-Fried after irregularities in a FedEx shipment and a misl...
Fort Worth is reshaping the Dallas-Fort Worth housing map as growth spreads to western suburbs. Analysts say fort wor...